These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29424334)

  • 21. Recurrent pediatric central nervous system low-grade gliomas: the role of surveillance neuroimaging in asymptomatic children.
    Udaka YT; Yeh-Nayre LA; Amene CS; VandenBerg SR; Levy ML; Crawford JR
    J Neurosurg Pediatr; 2013 Feb; 11(2):119-26. PubMed ID: 23157391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is it appropriate to redefine the indication for stereotactic brain biopsy in the MRI Era? Correlation with final histological diagnosis in supratentorial gliomas.
    Callovini GM
    Minim Invasive Neurosurg; 2008 Apr; 51(2):109-13. PubMed ID: 18401825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal herpes zoster encephalitis without a rash: diagnostic confusion between astrogliosis and low-grade glioma.
    Halling GC; Grose C
    Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1109-1111. PubMed ID: 27748148
    [No Abstract]   [Full Text] [Related]  

  • 24. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
    Santra A; Kumar R; Sharma P; Bal C; Kumar A; Julka PK; Malhotra A
    Eur J Radiol; 2012 Mar; 81(3):508-13. PubMed ID: 21353420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
    Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
    Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astroblastoma: report of two cases with unexpected clinical behavior and review of the literature.
    Janz C; Buhl R
    Clin Neurol Neurosurg; 2014 Oct; 125():114-24. PubMed ID: 25108699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Textiloma (gossypiboma) mimicking recurrent intracranial tumor.
    Ribalta T; McCutcheon IE; Neto AG; Gupta D; Kumar AJ; Biddle DA; Langford LA; Bruner JM; Leeds NE; Fuller GN
    Arch Pathol Lab Med; 2004 Jul; 128(7):749-58. PubMed ID: 15214828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult].
    Lamy-Lhullier C; Dubois F; Blond S; Lecouffe P; Steinling M
    Neurochirurgie; 1999 May; 45(2):110-7. PubMed ID: 10448650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiology: criteria for determining response to treatment and recurrence of high-grade gliomas.
    Lucas J; Zada G
    Neurosurg Clin N Am; 2012 Apr; 23(2):269-76, viii. PubMed ID: 22440870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system filariasis masquerading as a glioma: case report.
    Shrivastava A; Arora P; Khare A; Goel G; Kapoor N
    J Neurosurg; 2017 Sep; 127(3):691-693. PubMed ID: 28009239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
    Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
    Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
    Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
    AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data.
    Zetterling M; Roodakker KR; Berntsson SG; Edqvist PH; Latini F; Landtblom AM; Pontén F; Alafuzoff I; Larsson EM; Smits A
    J Neurosurg; 2016 Nov; 125(5):1155-1166. PubMed ID: 26918468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exophytic pontine glioma mimicking acoustic neurinoma: CT and MRI appearance.
    Ozawa Y; Katsumata Y; Maehara T
    Radiat Med; 1993; 11(5):217-9. PubMed ID: 8290700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical neuronal dysgenesis mimicking a malignant neoplasm.
    Goble KJ; Asfora WT; Ohrt D; Freeman JW
    S D J Med; 2002 Jul; 55(7):265-6. PubMed ID: 12148412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes.
    Capper D; Sahm F; Hartmann C; Meyermann R; von Deimling A; Schittenhelm J
    Am J Surg Pathol; 2010 Aug; 34(8):1199-204. PubMed ID: 20661018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis.
    Hayashi S; Kitamura Y; Hirose Y; Yoshida K; Sasaki H
    J Neurooncol; 2017 Mar; 132(1):119-126. PubMed ID: 28025770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.